The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
lnc RNA H19/miR‐675 axis represses prostate cancer metastasis by targeting TGFBI
Open accessAbstract
Prostate cancer is a leading cause of cancer‐related mortality in men worldwide and there is a lack of effective treatment options for advanced (metastatic) prostate cancer. Currently, limited knowledge is available concerning the role of long non‐coding RNA s in prostate cancer metastasis. In this study, we found that long non‐coding RNA H19 (H19) and H19‐derived microRNA‐675 (miR‐675) were significantly downregulated in the metastatic prostate cancer cell line M12 compared with the non‐metastatic prostate epithelial cell line P69. Upregulation of H19 in P69 and PC3 cells significantly increased the level of miR‐675 and repressed cell migration; however, ectopic expression of H19 in M12 cells could not increase the level of miR‐675 and therefore had no effect on cell migration. Furthermore, we found that the expression level of either H19 or miR‐675 in P69 cells was negatively associated with the expression of transforming growth factor β induced protein (TGFBI), an extracellular matrix protein involved in cancer metastasis. Dual luciferase reporter assays showed that miR‐675 directly bound with 3′UTR of TGFBI m RNA to repress its translation. Taken together, we show for the first time that the H19–miR‐675 axis acts as a suppressor of prostate cancer metastasis, which may have possible diagnostic and therapeutic potential for advanced prostate cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Silencing of microRNAs in vivo with ‘antagomirs’
Krützfeldt, J., Rajewsky, N., Braich, R., Rajeev, K. G., Tuschl, T., Manoharan, M., & Stoffel, M. (2005) · Nature · doi:10.1038/nature04303 · Cited by 3,949
Cancer treatment and survivorship statistics, 2012
Siegel, R., DeSantis, C., Virgo, K., Stein, K., Mariotto, A., Smith, T., Cooper, D., Gansler, T., Lerro, C., Fedewa, S., et al. (2012) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21149 · Cited by 2,928
The epithelial–mesenchymal transition: new insights in signaling, development, and disease
Lee, J. M., Dedhar, S., Kalluri, R., & Thompson, E. W. (2006) · The Journal of Cell Biology · doi:10.1083/jcb.200601018 · Cited by 2,019
Selective Blockade of MicroRNA Processing by Lin28
Viswanathan, S. R., Daley, G. Q., & Gregory, R. I. (2008) · Science · doi:10.1126/science.1154040 · Cited by 1,437
The Imprinted H19 LncRNA Antagonizes Let-7 MicroRNAs
Kallen, A. N., Zhou, X.-B., Xu, J., Qiao, C., Ma, J., Yan, L., Lu, L., Liu, C., Yi, J.-S., Zhang, H., et al. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.08.027 · Cited by 1,048
The H19 lincRNA is a developmental reservoir of miR-675 that suppresses growth and Igf1r
Keniry, A., Oxley, D., Monnier, P., Kyba, M., Dandolo, L., Smits, G., & Reik, W. (2012) · Nature Cell Biology · doi:10.1038/ncb2521 · Cited by 814
The imprinted H19 noncoding RNA is a primary microRNA precursor
Cai, X., & Cullen, B. R. (2007) · RNA · doi:10.1261/rna.351707 · Cited by 642
Target RNA–Directed Trimming and Tailing of Small Silencing RNAs
Ameres, S. L., Horwich, M. D., Hung, J.-H., Xu, J., Ghildiyal, M., Weng, Z., & Zamore, P. D. (2010) · Science · doi:10.1126/science.1187058 · Cited by 628
SKONIER, J., NEUBAUER, M., MADISEN, L., BENNETT, K., PLOWMAN, G. D., & PURCHIO, A. F. (1992) · DNA and Cell Biology · doi:10.1089/dna.1992.11.511 · Cited by 520
Up‐regulated long non‐coding RNA H19 contributes to proliferation of gastric cancer cells
Yang, F., Bi, J., Xue, X., Zheng, L., Zhi, K., Hua, J., & Fang, G. (2012) · The FEBS Journal · doi:10.1111/j.1742-4658.2012.08694.x · Cited by 464
Oncofetal H19-derived miR-675 regulates tumor suppressor RB in human colorectal cancer
Tsang, W. P., Ng, E. K. O., Ng, S. S. M., Jin, H., Yu, J., Sung, J. J. Y., & Kwok, T. T. (2010) · Carcinogenesis · doi:10.1093/carcin/bgp181 · Cited by 456
Self-citationThe xCELLigence System for Real-Time and Label-Free Monitoring of Cell Viability
Ke, N., Wang, X., Xu, X., & Abassi, Y. A. (2011) · Methods in Molecular Biology · doi:10.1007/978-1-61779-108-6_6 · Cited by 411
H19 acts as a trans regulator of the imprinted gene network controlling growth in mice
Gabory, A., Ripoche, M.-A., Le Digarcher, A., Watrin, F., Ziyyat, A., Forné, T., Jammes, H., Ainscough, J. F. X., Surani, M. A., Journot, L., et al. (2009) · Development · doi:10.1242/dev.036061 · Cited by 345
The H19 locus acts in vivo as a tumor suppressor
Yoshimizu, T., Miroglio, A., Ripoche, M.-A., Gabory, A., Vernucci, M., Riccio, A., Colnot, S., Godard, C., Terris, B., Jammes, H., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0801540105 · Cited by 336
Differential regulation of microRNA stability
Bail, S., Swerdel, M., Liu, H., Jiao, X., Goff, L. A., Hart, R. P., & Kiledjian, M. (2010) · RNA · doi:10.1261/rna.1851510 · Cited by 306
Bone metastasis in prostate cancer: emerging therapeutic strategies
Sturge, J., Caley, M. P., & Waxman, J. (2011) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2011.67 · Cited by 256
Kinetic Analysis Reveals the Fate of a MicroRNA following Target Regulation in Mammalian Cells
Baccarini, A., Chauhan, H., Gardner, T. J., Jayaprakash, A. D., Sachidanandam, R., & Brown, B. D. (2011) · Current Biology · doi:10.1016/j.cub.2011.01.067 · Cited by 235
Ma, C., Rong, Y., Radiloff, D. R., Datto, M. B., Centeno, B., Bao, S., Cheng, A. W. M., Lin, F., Jiang, S., Yeatman, T. J., et al. (2008) · Genes & Development · doi:10.1101/gad.1632008 · Cited by 224
Conservation of the H19 noncoding RNA and H19-IGF2 imprinting mechanism in therians
the SAVOIR Consortium, Smits, G., Mungall, A. J., Griffiths-Jones, S., Smith, P., Beury, D., Matthews, L., Rogers, J., Pask, A. J., Shaw, G., et al. (2008) · Nature Genetics · doi:10.1038/ng.168 · Cited by 198
Ibrahim, F., Rymarquis, L. A., Kim, E., Becker, J., Balassa, E., Green, P. J., & Cerutti, H. D. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0912632107 · Cited by 152
The imprinted H19 gene is a marker of early recurrence in human bladder carcinoma
Ariel, I. (2000) · Molecular Pathology · doi:10.1136/mp.53.6.320 · Cited by 146
OHLSSON, R. I., Hedborg, F., Holmgren, L., Walsh, C. P., & Ekström, T. J. (1994) · Development · doi:10.1242/dev.120.2.361 · Cited by 143
Metastatic sublines of an SV40 large T antigen immortalized human prostate epithelial cell line
Bae-Jump, V. L., Jackson‐Cook, C. K., Maygarden, S. J., Plymate, S. R., Chen, J., & Ware, J. L. (1998) · The Prostate · doi:10.1002/(sici)1097-0045(19980301)34:4<275::aid-pros5>3.0.co;2-g · Cited by 117
Liu, X., Chen, Q., Yan, J. Y., Wang, Y., Zhu, C., Chen, C., Zhao, X., Xu, M., Sun, Q., Deng, R., et al. (2013) · Cell Death and Disease · doi:10.1038/cddis.2013.458 · Cited by 115
Self-citationEvidence for evolutionarily conserved secondary structure in the H19 tumor suppressor RNA
Juan, V. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.5.1221 · Cited by 103
A Whole-Genome RNAi Screen for C. elegans miRNA Pathway Genes
Parry, D. H., Xu, J., & Ruvkun, G. (2007) · Current Biology · doi:10.1016/j.cub.2007.10.058 · Cited by 102
Expression of the imprinted gene H19 in the human fetus
Lustig, O., Ariel, I., Ilan, J., Lev-Lehman, E., de-Groot, N., & Hochberg, A. (1994) · Molecular Reproduction and Development · doi:10.1002/mrd.1080380302 · Cited by 99
Lin, B., Madan, A., Yoon, J., Fang, X., Yan, X. S., Kim, T., Hwang, D., Hood, L., & Foltz, G. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010210 · Cited by 85
Dao, D. N. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.7.1337 · Cited by 72
SUMOylation of Grb2 enhances the ERK activity by increasing its binding with Sos1
Qu, Y., Chen, Q., Lai, X., Zhu, C., Chen, C., Zhao, X., Deng, R., Xu, M., Yuan, H., Wang, Y., et al. (2014) · Molecular Cancer · doi:10.1186/1476-4598-13-95 · Cited by 67
Self-citationZhang, X., Fournier, M. V., Ware, J. L., Bissell, M. J., Yacoub, A., & Zehner, Z. E. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0544 · Cited by 63
Lustig, O., Schulze, E., Komitowski, D. D., Erdmann, V. A., Schneider, T., de Groot, N., & Hochberg, A. (1997) · Oncogene · doi:10.1038/sj.onc.1201175 · Cited by 60
Shang, D., Liu, Y., Yang, P., Chen, Y., & Tian, Y. (2012) · Urology · doi:10.1016/j.urology.2011.12.011 · Cited by 57
Hourihan, R. N., O’Sullivan, G. C., & Morgan, J. (2003) · PubMed · Cited by 56
Uracils at nucleotide position 9–11 are required for the rapid turnover of miR-29 family
Zhang, Z., Zou, J., Wang, G.-K., Zhang, J.-T., Huang, S., Qin, Y.-W., & Jing, Q. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr020 · Cited by 50
Role of long non-coding RNA in cells: Example of the H19/IGF2 locus
Vennin, C., Dahmani, F. Z., Spruyt, N., & Adriaenssens, É. (2013) · Advances in Bioscience and Biotechnology · doi:10.4236/abb.2013.45a004 · Cited by 17
Cited by
Non-coding RNA networks in cancer
Anastasiadou, E., Jacob, L. S., & Slack, F. J. (2018) · Nature Reviews Cancer · doi:10.1038/nrc.2017.99 · Cited by 1,884
Long noncoding RNAs in cancer metastasis
Liu, S. J., Dang, H. X., Lim, D. A., Feng, F. Y., & Maher, C. A. (2021) · Nature Reviews Cancer · doi:10.1038/s41568-021-00353-1 · Cited by 648
Raveh, E., Matouk, I. J., Gilon, M., & Hochberg, A. (2015) · Molecular Cancer · doi:10.1186/s12943-015-0458-2 · Cited by 525
Huang, Y., Zheng, Y., Jia, L., & Li, W. (2015) · Stem Cells · doi:10.1002/stem.2225 · Cited by 303
Interaction and cross-talk between non-coding RNAs
Yamamura, S., Imai-Sumida, M., Tanaka, Y., & Dahiya, R. (2018) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2626-6 · Cited by 302
Metadata
- Authors
- Zhu, M., Chen, Q., Liu, X., Sun, Q., Zhao, X., Deng, R., Wang, Y., Huang, J., Xu, M., Yan, J., & Yu, J.
- Venue
- The FEBS Journal
- Publisher
- Wiley
- Published
- 2014-07-21
- Volume
- 281
- Issue
- 16
- Pages
- 3766-3775
- ISSN
- 1742-464X (ISSN-L)
- 1742-4658
- OpenAlex
- W2028205153
- Cited by
- 299
- References
- 36
- FWCI
- 9.53
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.